Efficacy Ultrasound-guided Genicular Nerve Radiofrequency Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Radiofrequency (RF) application is a treatment method that temporarily blocks pain transmission in the nerve where the application is made, through the heat emitted by radio waves. Genicular nerve ablation with RF has recently become a promising treatment option for the treatment of chronic knee pain. These methods are based on the principle that interfering with the sensory nerve fibers of a painful structure can relieve pain and restore function. Their targets are sensory nerves located on the periosteum before entering the knee joint capsule. The knee joint is innervated by a complex nerve network called genicular nerves, which are articular branches of many nerves such as the femoral, tibial, peroneal, saphenous and obturator nerves. Some of the genicular nerves can be easily localized. The intermedius genicular nerve carries the sensation of subpatellar pain. The intermedius genicular nerve is located under the vastus intermedius muscle, anterior to the distal femoral shaft, just above the bony cortex. Targeting sensory nerves in addition to standard procedures and improving target identification using ultrasound guidance may increase treatment success. The aim of this study is to investigate the effect of ultrasound-guided genicular nerve radiofrequency therapy on pain and knee function by targeting only the traditional 3 genicular nerves and the intermedius genicular nerve in addition to the traditional genicular nerves in advanced gonarthrosis patients with prominent anterior knee pain.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Ultrasound-Guided Genicular Nerve Radiofrequency Ablation Therapy

NCT06914960

Gonarthrosis

RECRUITING NA

The Effect of Radiofrequency Ablation on the Results of the Genicular Nerve Number in the Treatment of Knee Osteoarthritis

NCT05447624

Osteoarthritis, Knee Radiofrequency Ablation Genicular Nerve

COMPLETED NA

Genicular Radiofrequency Ablation Versus Pulsed Radiofrequency

NCT06894147

Osteoarthritis of Knee

ACTIVE_NOT_RECRUITING NA

Comparative Effectiveness of Genicular Nerve Radiofrequency Thermocoagulation and Intra-Articular Pulsed Radiofrequency in the Management of Knee Osteoarthritis Pain

NCT07098455

Knee Osteoarthristis Radiofrequency Ablation

ACTIVE_NOT_RECRUITING NA

Evaluation of Radiofrequency Neurolysis and Chemical Neurolysis of the Genicular Nerves

NCT05340166

Knee Osteoarthritis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Our study was designed as a prospective, single-blind randomized controlled study. Patients who applied to our hospital's FTR outpatient clinic and were diagnosed with advanced stage gonarthrosis with anterior knee pain after physical examination and imaging evaluation will be included in our study. The sample size was done using G\*Power 3.1.9.4 statistical power analysis program for Windows. Based on the study conducted by the effectiveness of genicular RF treatment in chronic knee pain in knee osteoarthritis, the number of patients who will provide a 20% significant change in the pre-treatment and 3rd month WOMAC total evaluation (with a margin of error of 5% Type 1 and 20% Type 2, a study power of 80% and a confidence interval of 95%) is determined for each The minimum required number of patients for a group was found to be 30 patients. Considering that there may be a 20% loss during the study, it was decided to include at least 36 patients for each group. Patients who met the inclusion criteria and completed the "Informed Volunteer Consent Forum" were selected for the first group with the "Research Randomizer" computer program. The patients will be randomized into two groups of 36 people: the three-nerve RF Group (3RFG), the second group will be the four-nerve RF Group (4RFG). The physician performing the evaluation will be blind to which procedure is performed. The demographic and clinical characteristics of the patients will be recorded. Patients will be evaluated using the "Visual Analogue Scale (VAS)" for knee pain assessment as the primary outcome measure, and the patients will be evaluated for climbing/descending stairs, squatting, walking, jogging, sprinting, sports activities, sitting with knees 90° flexed for 20 minutes, "Patella Femoral Pain Severity Scale" will be used to evaluate the pain that occurs while kneeling, at rest and after an activity, and "Kujala Patellofemoral Scoring System" and WOMAC will be used to determine the functional levels of the patients. These evaluations will be made and recorded at the beginning, at the 4th and 12th weeks after the procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gonarthrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Our study was designed as a prospective, single-blind randomized controlled study. Patients who applied to our hospital's PMR outpatient clinic and were diagnosed with advanced stage gonarthrosis with anterior knee pain after physical examination and imaging evaluation will be included in our study. Patients were selected for the first group with the "Research Randomizer" computer program. The patients will be randomized into two groups of 36 people: the three-nerve RF Group (3RFG), the second group will be the four-nerve RF Group (4RFG). The physician performing the evaluation will be blind to which procedure is performed. The demographic and clinical characteristics of the patients will be recorded. Patients will be evaluated using the Visual Analogue Scale (VAS),Patella Femoral Pain Severity Scale and Kujala Patellofemoral Scoring System and WOMAC. These evaluations will be made and recorded at the beginning, at the 4th and 12th weeks after the procedure.

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

The physician performing the evaluation will be blind to which procedure is performed

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

3 nerves protocol

tradiational the three-nerve genicular RF Group (3RFG),

Group Type ACTIVE_COMPARATOR

Genicular nerve pulse radiofrequency ablation 3

Intervention Type PROCEDURE

Ultrasound-guided genicular nerve radiofrequency therapy targets only the traditional 3 genicular nerves

4 nerves protocol

targeting the intermedius genicular nerve in addition to traditional genicular nerves four-nerve genicular RF Group (4RFG),

Group Type ACTIVE_COMPARATOR

Genicular nerve pulse radiofrequency ablation 4

Intervention Type PROCEDURE

Ultrasound-guided genicular nerve radiofrequency therapy targets only the traditional 3 genicular nerves and the intermedius genicular nerve in addition to the traditional genicular nerves.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Genicular nerve pulse radiofrequency ablation 3

Ultrasound-guided genicular nerve radiofrequency therapy targets only the traditional 3 genicular nerves

Intervention Type PROCEDURE

Genicular nerve pulse radiofrequency ablation 4

Ultrasound-guided genicular nerve radiofrequency therapy targets only the traditional 3 genicular nerves and the intermedius genicular nerve in addition to the traditional genicular nerves.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Being a male/female \>18
2. K-L stage 3-4 gonarthrosis patients with anterior knee pain and positive patellofemoral pain tests after physical examination and imaging evaluation
3. Those whose symptoms persist for \>3 months
4. Participating in the study voluntarily

Exclusion Criteria

1. Pregnancy
2. History of previous knee surgery
3. Having received physical therapy in the knee area in the last 3 months
4. Having previously undergone RF treatment or having had any therapeutic injection such as steroids or hyaluronic acid within 3 months.
5. Those with pain referred to the waist or hip
6. Patients with neuropathic pain
7. History of tumor, infectious, psychiatric disease, bleeding diathesis
8. Having a history of knee trauma in the last 6 months
9. Those with systemic diseases such as hepatitis and coagulopathy
10. Patients with BMI \>40
11. Leg length difference

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No